Our results demonstrate that a high ATAD2 level is significantly associated with a worse outcome in ACC, KIRP, LGG, LUAD, MESO, PAAD TCGA tumors, strongly suggesting that ATAD2 overexpression favors malignant transformation of unrelated cancer types. This evidence concerns the gene ATAD2 and adrenal cortex carcinoma.